2022
DOI: 10.3390/pharmaceutics14091966
|View full text |Cite
|
Sign up to set email alerts
|

Novel 3D-Printed Dressings of Chitosan–Vanillin-Modified Chitosan Blends Loaded with Fluticasone Propionate for Treatment of Atopic Dermatitis

Abstract: In the present study, the blends of CS and Vanillin–CS derivative (VACS) were utilized for the preparation of printable inks for their application in three-dimensional (3D) printing procedures. Despite the synergic interaction between the blends, the addition of ι-carrageenan (iCR) as a thickening agent was mandatory. Their viscosity analysis was conducted for the evaluation of the optimum CS/VACS ratio. The shear thinning behavior along with the effect of the temperature on viscosity values were evident. Furt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 63 publications
0
3
0
Order By: Relevance
“…The positive values of the µ and α factors prove the miscibility of the blends in all the studied ratios. Furthermore, the strong interactions between the CS and CS-MVP polymers in the ratios of 60:40, 50:50, and 40:60 are also evident in Figure 8e, CS blends have already been examined by our group for drug delivery of chloramphenicol [27] and fluticasone propionate, and their application in 3D printing has already been established [11,43]. Within this scope, concentrated inks of high viscosity were formulated with the CS/CS-MVP blends, and their potential application in pneumatic 3D extrusion was examined.…”
Section: Cs/cs-mvp Inksmentioning
confidence: 79%
See 1 more Smart Citation
“…The positive values of the µ and α factors prove the miscibility of the blends in all the studied ratios. Furthermore, the strong interactions between the CS and CS-MVP polymers in the ratios of 60:40, 50:50, and 40:60 are also evident in Figure 8e, CS blends have already been examined by our group for drug delivery of chloramphenicol [27] and fluticasone propionate, and their application in 3D printing has already been established [11,43]. Within this scope, concentrated inks of high viscosity were formulated with the CS/CS-MVP blends, and their potential application in pneumatic 3D extrusion was examined.…”
Section: Cs/cs-mvp Inksmentioning
confidence: 79%
“…CS blends have already been examined by our group for drug delivery of chloramphenicol [27] and fluticasone propionate, and their application in 3D printing has already been established [11,43]. Within this scope, concentrated inks of high viscosity were formulated with the CS/CS-MVP blends, and their potential application in pneumatic 3D extrusion was examined.…”
Section: Cs/cs-mvp Inksmentioning
confidence: 99%
“…It is noteworthy that the OAX/CS blend with the highest CS concentration (OAX/CS 1 : 2) demonstrated an effective drug release profile attributed to its minimal swelling ratio, as result of intermolecular hydrogen bonding between the −NH 2 − group of CS and the carbonyl group of OAX. This resulted in a gradual and sustained release of the drug, which highlights its potential as a favorable candidate for sustained drug delivery applications [58,59] .…”
Section: Resultsmentioning
confidence: 99%